Table 1 Characteristics of 128 patients with sustained viral suppression after 4 years of highly active antiretroviral therapy (HAART) in an urban African cohort

Age (yrs)

38 (33-44)

Female gender n (%)

94 (73%)

Body mass index (BMI), median (IQR)

22 (20-25)

Baseline CD4 count (cells/μl), median (IQR)

102 (38-167)

CD4 count after 4 years of ART (cells/μl) median (IQR)

327 (247-454)

HAART regimen

Stavudine-Lamividine-Nevirapine/Efavirenz [n (%)]

55 (43%)

Zidovidine-Lamivudine- Nevirapine/Efavirenz [n (%)]

67 (52%)

Tenofovir-Emitricitabine-Nevirapine/Efavirenz [n (%)]

6 (5%)

Haemogram

Total white count, median (IQR)

4429 (3300-5040)

Percentage neutrophils, median (IQR)

44 (37-53)

Percentage lymphocytes, median (IQR)

43(32-47)

Percentage eosinophils, median (IQR)

2 (1-6)

Haemoglobin (mg/dl), median (IQR)

14 (12-15)